| 1 |
Kim CK, Callaway Z, Kim DW, Kita H. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough. J Asthma 2011;48:994-1000.
DOI
ScienceOn
|
| 2 |
Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001;26:79-82.
DOI
ScienceOn
|
| 3 |
Wilson NM, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000;55:768-74.
DOI
ScienceOn
|
| 4 |
Wojnarowski C, Roithner B, Koller DY, Halmerbauer G, Gartner C, Tauber E, et al. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study. Clin Exp Allergy 1999;29: 926-32.
DOI
ScienceOn
|
| 5 |
Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
DOI
|
| 6 |
Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172-86.
DOI
ScienceOn
|
| 7 |
Goto T, Morioka J, Inamura H, Yano M, Kodaira K, Igarashi Y, et al. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 2007;56:433-8.
DOI
ScienceOn
|
| 8 |
Koller DY, Halmerbauer G, Frischer T, Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma? Clin Exp Allergy 1999;29:786-93.
DOI
ScienceOn
|
| 9 |
Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999;159:1918-24.
DOI
ScienceOn
|
| 10 |
Kim CK, Choi J, Kim HB, Callaway Z, Shin BM, Kim JT, et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation. J Pediatr 2010;156:749-54.
DOI
ScienceOn
|
| 11 |
Papadopoulos NG, Papi A, Meyer J, Stanciu LA, Salvi S, Holgate ST, et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2001;31: 1060-6.
DOI
ScienceOn
|
| 12 |
Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin- 4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002;186: 1207-11.
DOI
ScienceOn
|
| 13 |
Parkin PC, Macarthur C, Saunders NR, Diamond SA, Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 1996;49: 821-5.
DOI
ScienceOn
|
| 14 |
Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010;47:568-73.
DOI
ScienceOn
|
| 15 |
Kim CK, Kita H, Callaway Z, Kim HB, Choi J, Fujisawa T, et al. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol 2010;21(4 Pt 2):e697-704.
DOI
ScienceOn
|
| 16 |
Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709-50.
DOI
ScienceOn
|
| 17 |
Parameswaran K, Pizzichini E, Pizzichini MM, Hussack P, Efthimiadis A, Hargreave FE. Clinical judgement of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J 2000;15:486-90.
DOI
|
| 18 |
The Global Initiative for Asthma. GINA report, global strategy for asthma management and prevention. Updated Dec. 2011 [Internet]. [place unknown]: The Global Initiative For Asthma; c2011. [cited 2011 Jun 21]. Available from: http://www.ginasthma.org/guidelinesgina- report-global-strategy-for-asthma.html.
|
| 19 |
British Thoracic Society. 2008 British guideline on the management of asthma: a national clinical guideline. Updated Jun. 2009 [Internet]. London: British Thoracic Society; c2011 [cited 2011 Jun 21]. Available from: http://www.brit-thoracic.org.uk/guidelines/ asthma-guidelines.aspx.
|
| 20 |
Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9.
DOI
ScienceOn
|
| 21 |
Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, et al. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999;13:15-21.
DOI
ScienceOn
|
| 22 |
Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000;161:64-72.
DOI
ScienceOn
|
| 23 |
Venge P. Monitoring the allergic inflammation. Allergy 2004;59: 26-32.
DOI
ScienceOn
|
| 24 |
Gleich GJ, Adolphson CR. The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology. In: Sanderson CJ, editor., Interleukin-5: from molecule to drug target for asthma (lung biology in health disease). New York: Marcel Dekker, 1999:1-37.
|
| 25 |
Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung 2007;185:97-103.
DOI
ScienceOn
|
webmaster
